Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Aug 6.
Published in final edited form as: J Am Chem Soc. 2017 Jan 25;139(5):1742–1745. doi: 10.1021/jacs.6b10901

Biosynthesis of Branched Alkoxy Groups: Iterative Methyl Group Alkylation by a Cobalamin-Dependent Radical SAM Enzyme

Yuanyou Wang , Bastien Schnell , Sascha Baumann , Rolf Müller , Tadhg P Begley †,*
PMCID: PMC6078419  NIHMSID: NIHMS979249  PMID: 28040895

Abstract

The biosynthesis of branched alkoxy groups, such as the unique t-butyl group found in a variety of natural products, is still poorly understood. Recently, cystobactamids were isolated and identified from Cystobacter sp as novel antibacterials. These metabolites contain an isopropyl group proposed to be formed using CysS, a cobalamin-dependent radical S-adenosylmethionine (SAM) methyltransferase. Here, we reconstitute the CysS-catalyzed reaction, on p-aminobenzoate thioester substrates, and demonstrate that it not only catalyzes sequential methylations of a methyl group to form ethyl and isopropyl groups but remarkably also sec-butyl and t-butyl groups. To our knowledge, this is the first in vitro reconstitution of a cobalamin-dependent radical SAM enzyme catalyzing the conversion of a methyl group to a t-butyl group.


Natural products with branched alkoxy groups play an important role in the development of bioactive compounds. In addition, the t-butyl group has fascinated organic chemists for more than a century and has played a major role in mechanistic studies on carbocation chemistry, organic substitution reactions, and the design and characterization of theoretically interesting molecules such as the remarkable tetra t-butyl tetrahedrane.1 Although numerous t-butyl group substituted terpenes, polyketides and peptides have been identified, experimental studies on the biosynthesis of t-butyl groups are still at an early stage and many of the mechanistic proposals in the literature have not been adequately experimentally tested.2

For the ginkgolides and several other t-butyl substituted terpenes, the t-butyl group is formed by a double bond methylation using S-adenosylmethionine (Figure 1A).3 Formation of the t-butyl group in the coumarin swietenone is proposed to involve carbocation insertion into a CH bond to give a cyclopropyl intermediate, which then undergoes acid mediated ring-opening (Figure 1B).4 The biosynthesis of pivalic acid, a starter unit in the biosynthesis of t-butyl substituted polyketides, is mediated by a vitamin B12-dependent enzyme (Figure 1C).5,6 Very recently, the B12/radical SAM mediated conversion of isopropyl glycine to t-butyl glycine in the polytheoamide propeptide was reported (Figure 1D).7,8 The latter two enzymes are the only t-butyl biosynthesis enzymes that have been experimentally reconstituted.

Figure 1.

Figure 1

Mechanistic proposals for the formation of the t-butyl group in representative natural products.

Radical SAM enzymes use the 5′-deoxyadenosyl radical (5′-dA·), generated by reductive cleavage of SAM, to initiate a diverse set of radical reactions.9 A subfamily of these enzymes combines adenosyl radical chemistry with methyl cobalamin chemistry enabling the methylation of non-nucleophilic centers in natural product biosynthesis.10

Cobalamin-dependent radical SAM methyltransferases are experimentally challenging and are generally difficult to overproduce. Only a few systems have been reconstituted.11 These include enzymes that catalyze phosphinic acid methylation (PhpK, L-phosphinothricin biosynthesis),12 alcohol C-methylation (GenK, gentamicin biosynthesis13 and Fom3, fosfomycin biosynthesis14), iterative C-methylation to form the ethyl group (ThnK, carbapenem biosynthesis)15 and indole C-methylation (TsrM, thiostrepton biosynthesis).16

The cystobactamids 17 are a novel class of isopropyl substituted antibacterial compounds produced by myxobacteria. 17 The biosynthetic gene cluster has been identified and sequence analysis suggested that CysS is a cobalamin-dependent radical SAM methyltransferase, potentially involved in the iterative methylations of the 3-methoxy-4-aminobenzoic acid moieties of cystobactamid 15 (Figure 2). Some minor derivatives exhibit methyl, ethyl, isopropyl, and sec-butyl groups (Stephan Hüttel and R.M., unpublished results) supporting the hypothesis of CysS being an enzyme iteratively adding methyl-groups to its substrate.

Figure 2.

Figure 2

Proposed formation of branched alkoxy groups of cystobactamids by CysS-catalyzed iterative methylations of a methyl ether.

To test this hypothesis, an in vivo labeling experiment using [13C-methyl]-L-methionine was performed to determine the origin of the isopropyl groups on cystobactamid 919-1 (17b). LC-MS analysis of the extracts showed a mass shift of +7 Da indicating that all seven carbons from the methoxy and both isopropyl groups were from methionine and therefore most likely SAM derived (Figure 3).

Figure 3.

Figure 3

MS analysis of cell extracts containing (A) methionine and (B) [13C-methyl]-L-methionine showing the incorporation of up to seven 13C in cystobactamid 919-1.

Here we describe the successful in vitro reconstitution of CysS and demonstrate that this enzyme can assemble isopropyl, sec-butyl, and t-butyl groups by sequential methylations of a methyl group. To our knowledge, this is the first example of an isopropyl, sec-butyl, and a t-butyl group biosynthesis from a methyl group using radical chemistry. Sequence analysis suggests that related chemistry is involved in the biosynthesis of other natural products such as SW-163G18 and bottromycin.19,20

CysS was cloned into a pET28b vector and coexpressed with a plasmid encoding the suf operon ([4Fe-4S] biosynthesis)21 in Escherichia coli BL21 (λDE3). The protein was then purified, under anaerobic conditions, by Ni-NTA affinity chromatography. Cobalamin was not required in the growth medium for production of soluble protein. The UV–visible spectrum of purified CysS revealed a 420nmshoulder, typical of a bound Fe/S cluster (Figure S1). Iron and sulfide analysis yielded 2.5 irons and 2.8 sulfides per monomer of CysS, demonstrating partial cluster formation in the overexpressed protein.

Several p-aminobenzoic acid (PABA) analogs were tested as substrates for CysS (Table S1). None gave the desired methylated product as indicated by LC-MS analysis. Further analysis of the cystobactamid biosynthesis cluster suggested the coenzyme A or the acyl carrier protein thioester of 15 (CysG)17 as possible CysS substrates. To test this proposal, N-acetylcysteamine thioester 18 was synthesized and incubated with CysS, SAM, MeCbl, and flavodoxin/flavodoxin reductase/NADPH (Figure 4). LC-MS analysis of the resulting reaction mixture demonstrated the formation of the ethyl ether 19. This was further confirmed by coelution of the reaction product with a synthesized sample of 19 (Figure S2). When the ethyl ether 19 was incubated with CysS, the isopropyl ether 20 was detected by LC-MS analysis (Figure S2).

Figure 4.

Figure 4

Identification of two substrates for CysS. A competition reaction with a 1:1 mixture demonstrated that 21 is 47 times more reactive than 18 (Supporting Information).

Pantetheinyl thioester 21 was a better substrate for CysS and iterative methylations to give the ethyl, isopropyl, and the butyl ethers were detected by LC-MS analysis (Figure 5). Small amounts of the ethers 22a and 22b were detected in the absence of the reducing agent suggesting that some of the purified enzyme contained the reduced [4Fe–4S] cluster. To confirm the structures of 22a–c, authentic samples of these compounds were synthesized. The enzymatic products matched the synthetic standards in terms of retention time, exact mass, and fragmentation pattern (Figure 5, Figures S3–5). In addition, CysS catalyzed the conversion of synthetic 22a to 22b–d and the conversion of synthetic 22b to 22c,d (Figure S6). The second component in the extracted ion chromatogram for the t-butyl ether 22c (Figure 5C,D) was identified as the sec-butyl ether 22d by comigration with an authentic standard of 22d (Figure S7).

Figure 5.

Figure 5

LC-MS analysis of CysS-catalyzed iterative methylations of methyl ether 21. Red trace is for the complete reaction mixture. Green trace is for reaction mixtures where the reducing system (flavodoxin/flavodoxin reductase/NADPH) is absent. Ethyl ether 22a, isopropyl ether 22b were not formed in the control reactions lacking CysS, SAM, or MeCbl. (A) Extracted ion chromatograms (EICs) of the ethyl ether 22a [M +H]+ (442.20±0.02). (B) EICs of the isopropyl ether 22b [M+H]+ (456.22 ± 0.02). (C) EICs of the t-butyl ether 22c [M + H]+ (470.23 ± 0.02). (D) EICs of[M+H]+ (470.23±0.02) showing comigration with a synthesized sample of 22c. Cyan trace is the t-butyl ether standard. Blue trace is coelution of the enzymatic product and synthetic standard. The second component in the extracted ion chromatogram for the t-butyl ether 22c (panels C, D) was identified as the sec-butyl ether 22d (Figure S7). The product ratio was determined by calibrating signal intensity with known concentrations of standards (SI).

Various [4Fe–4S] cluster reducing agents were tested in addition to the flavodoxin/flavodoxin reductase/NADPH. NADPH/methyl viologen, a commonly used electron source for cobalamin-dependent radical SAM enzymes, gave similar activity.13,15 However, dithionite or the combination of methyl viologen and dithionite gave a significantly lower activity.22 Buffer thiols inactivate the substrate by trans thioesterification and need to be avoided.

Quantitative analysis of the enzymatic reaction mixture (CysS, methyl ether 21, flavodoxin/flavodoxin reductase/NADPH, reaction run to completion) by LC-MS showed that 1 equiv of enzyme undergoes >2 turnovers, generating around 2.0 equiv of 5′-dA, 2.0 equiv of SAH, 1.4 equiv of ethyl ether 22a and 0.3 equiv of isopropyl ether 22b (Figures 5 and 6, SI). The t-butyl ether 22c was detected only when the concentration of the isopropyl ether 22b was >23 μM. The ratio of 5′-dA to SAH was close to 1, suggesting that two molecules SAM were consumed for each methylation reaction and that the uncoupled production of 5′-dA is low. This is consistent with SAM functioning as the source of both the adenosyl radical and the methyl group and was further supported by LC-MS analysis of a reaction mixture containing CD3-SAM which demonstrated CD3 incorporation into the ethyl ether 22a and the isopropyl ether 22b (Figure 7).

Figure 7.

Figure 7

MS analysis of a reaction mixture in which CH3-SAM is replaced with CD3-SAM showing CD3 incorporation into the ethyl and isopropyl ethers of 22a and 22b, respectively. Panels A and C: Mass spectra of 22a and 22b formed from CH3-SAM. Panels B and D: Mass spectra of 22a and 22b formed from CD3-SAM.

A mechanistic proposal for the CysS-catalyzed reaction, based on the proposed mechanisms forGenK13 and ThnK,15 is shown in Figure 8. After initial formation of methylcobalamin by SAM mediated methylation, reductive cleavage of SAM by the [4Fe–4S]+1 cluster generates the 5′-deoxyadenosyl radical. This abstracts a hydrogen atom from the methyl group of the substrate 21 to give radical 23, which then undergoes a radical substitution with methyl cobalamin to give the ethyl ether 22a. An analogous methyl transfer, by a radical substitution mechanism, has precedence in cobalamin model chemistry.23 Regeneration of MeCbl from Cbl(II) can be achieved by reduction to Cbl(I) by the [4Fe–4S]+1 cluster followed by SAM-mediated methylation. Repetition of this sequence results in the successive formation of the isopropyl, t-butyl, and sec-butyl ethers of 21. The in vitro ratio of branched alkoxy groups is likely to be different from the in vivo ratio because in vivo each methylation in the iterative sequence is in competition with the next step in the biosynthesis. This is not the case for the purified enzyme where no such competition exists thus allowing for the formation of higher levels of the t-butyl ether. Our studies on CysS suggest that t-butyl substituted cystobactamids, which have not yet been isolated, are likely to exist.

Figure 8.

Figure 8

Proposal for CysS-catalyzed iterative methylations to form branched alkoxy groups. The mechanism assumes two different SAM binding sites. It is also possible that SAM binds to a single site and that the position of the sulfonium moiety is altered by a protein conformational change.

In summary, we have elucidated the enzymology of a radical-mediated conversion of a methyl ether to a t-butyl ether. CysS is a cobalamin dependent radical SAM methyltransferase that catalyzes the iterative methylation of a substrate methyl ether to give ethyl, isopropyl, t-butyl, and sec-butyl substituted products. Each methyl transfer is likely to proceed via hydrogen atom abstraction from the evolving carbon of the substrate followed by a radical substitution on methyl cobalamin. This biosynthetic strategy in principle enables the host myxobacterium to biosynthesize a combinatorial antibiotic library of 25 cystobactamid analogs. The analysis of the impact of these molecular decorations on bioactivity will be the task of future studies.

Supplementary Material

SI

Figure 6.

Figure 6

LC-MS detection of 5′-dA and SAH in the CysS-catalyzed iterative methylations of the methyl ether 21. Red trace is for the complete reaction mixture. Green trace is for reaction mixtures where the reducing system (flavodoxin/flavodoxin reductase/NADPH) is absent. (A) EICs of 5′-dA [M+ H]+ (252.11±0.02). (B) EICs of SAH [M +H]+ (385.13 ± 0.02). Yellow, green, cyan, and black traces are for reaction mixtures where either CysS, reducing system, MeCbl or substrate is absent. The product ratio was determined by calibrating the signal intensity with known concentrations of standards (SI).

Acknowledgments

This work was supported by NIH (DK44083) and by the Robert A. Welch Foundation (A-0034) as well as the German Centre for Infection Research (DZIF).

Footnotes

Notes

The authors declare no competing financial interest.

Supporting Information

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/jacs.6b10901.

Experimental details (PDF)

References

  • 1.Maier G, Pfriem S, Schafer U, Matusch R. Angew Chem, Int Ed Engl. 1978;17:520–521. [Google Scholar]
  • 2.Bisel P, Al-Momani L, Müller M. Org Biomol Chem. 2008;6:2655–2665. doi: 10.1039/b800083b. [DOI] [PubMed] [Google Scholar]
  • 3.Nakanishi K, Habaguchi K. J Am Chem Soc. 1971;93:3546–3547. [Google Scholar]
  • 4.Mujumdar RB, Rao AVR, Rathi SS, Venkataraman K. Tetrahedron Lett. 1975;16:867–868. [Google Scholar]
  • 5.Rezanka T, Kolouchova I, Cejkova A, Sigler K. Appl Microbiol Biotechnol. 2012;95:1371–1376. doi: 10.1007/s00253-012-4267-x. [DOI] [PubMed] [Google Scholar]
  • 6.Kitanishi K, Cracan V, Banerjee R. J Biol Chem. 2015;290:20466–76. doi: 10.1074/jbc.M115.646299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Parent A, Guillot A, Benjdia A, Chartier G, Leprince J, Berteau O. J Am Chem Soc. 2016;138:15515–15518. doi: 10.1021/jacs.6b06697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Freeman MF, Helf MJ, Bhushan A, Morinaka BI, Piel J. Nat Chem. 2016 doi: 10.1038/nchem.2666. [DOI] [PubMed] [Google Scholar]
  • 9.Broderick JB, Duffus BR, Duschene KS, Shepard EM. Chem Rev. 2014;114:4229–4317. doi: 10.1021/cr4004709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zhang Q, van der Donk WA, Liu W. Acc Chem Res. 2012;45:555–564. doi: 10.1021/ar200202c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bauerle MR, Schwalm EL, Booker SJ. J Biol Chem. 2015;290:3995–4002. doi: 10.1074/jbc.R114.607044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Werner WJ, Allen KD, Hu KF, Helms GL, Chen BS, Wang SC. Biochemistry. 2011;50:8986–8988. doi: 10.1021/bi201220r. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kim HJ, McCarty RM, Ogasawara Y, Liu YN, Mansoorabadi SO, LeVieux J, Liu HW. J Am Chem Soc. 2013;135:8093–8096. doi: 10.1021/ja312641f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Allen KD, Wang SC. Arch Biochem Biophys. 2014;543:67–73. doi: 10.1016/j.abb.2013.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Marous DR, Lloyd EP, Buller AR, Moshos KA, Grove TL, Blaszczyk AJ, Booker SJ, Townsend CA. Proc Natl Acad Sci U S A. 2015;112:10354–10358. doi: 10.1073/pnas.1508615112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Benjdia A, Pierre S, Gherasim C, Guillot A, Carmona M, Amara P, Banerjee R, Berteau O. Nat Commun. 2015;6:8377. doi: 10.1038/ncomms9377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Baumann S, Herrmann J, Raju R, Steinmetz H, Mohr KI, Huttel S, Harmrolfs K, Stadler M, Müller R. Angew Chem, Int Ed. 2014;53:14605–9. doi: 10.1002/anie.201409964. [DOI] [PubMed] [Google Scholar]
  • 18.Watanabe K, Hotta K, Nakaya M, Praseuth AP, Wang CC, Inada D, Takahashi K, Fukushi E, Oguri H, Oikawa H. J Am Chem Soc. 2009;131:9347–53. doi: 10.1021/ja902261a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Huo LJ, Rachid S, Stadler M, Wenzel SC, Müller R. Chem Biol. 2012;19:1278–1287. doi: 10.1016/j.chembiol.2012.08.013. [DOI] [PubMed] [Google Scholar]
  • 20.Crone WJK, Leeper FJ, Truman AW. Chem Sci. 2012;3:3516–3521. [Google Scholar]
  • 21.Hanzelmann P, Hernandez HL, Menzel C, Garcia-Serres R, Huynh BH, Johnson MK, Mendel RR, Schindelin H. J Biol Chem. 2004;279:34721–32. doi: 10.1074/jbc.M313398200. [DOI] [PubMed] [Google Scholar]
  • 22.Salnikov DS, Silaghi-Dumitrescu R, Makarov SV, van Eldik R, Boss GR. Dalton T. 2011;40:9831–9834. doi: 10.1039/c1dt10219b. [DOI] [PubMed] [Google Scholar]
  • 23.Mosimann H, Kräutler B. Angew Chem, Int Ed. 2000;39:393–395. doi: 10.1002/(sici)1521-3773(20000117)39:2<393::aid-anie393>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI

RESOURCES